Phase Ib/II Clinical Study of SHR-8068 Combined With Adebrelimab and Other Anti-tumor Drugs in the Treatment of Advanced Renal Cell Carcinom

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Advanced Renal Cell Carcinoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Beijing Cancer Hospital, Beijing, Beijing Municipality, China
Contact: Principal Investigator (Jun Guo)

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Ipilimumab or Cabozantinib in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208)

Advanced Renal Cell Carcinoma (RCC)

Abroad (travel likely)RecruitingPHASE1, PHASE2

Palo Alto, United States · New Haven, United States

A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors

Melanoma · Non-small Cell Lung Cancer · Squamous Cell Carcinoma (Skin)

Abroad (travel likely)RecruitingPHASE1, PHASE2

Grand Rapids, United States · St Louis, United States

A Randomized Trial of Fianlimab and Cemiplimab +/- Ipilimumab or Ipilimumab Plus Nivolumab in First-line Advanced Renal Cell Carcinoma (RCC)

Advanced Renal Cell Carcinoma (aRCC) · Metastatic Renal Cell Carcinoma ( mRCC) · Clear Cell Renal Cell Carcinoma (ccRCC)

Abroad (travel likely)RecruitingPHASE2

Nashville, United States · Milwaukee, United States

Neoadjuvant Zanzalintinib Plus Nivolumab in Patients With Locally Advanced and/or Inoperable Clear Cell Renal Cell Carcinoma With or Without Non-measurable Metastasis

Locally Advanced Renal Cell Carcinoma

Abroad (travel likely)RecruitingPHASE2

St Louis, United States · Dallas, United States